Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radiopharmaceutical drug. Each syringe shield and vial shield must also be labeled unless the label on the syringe or vial is visible when shielded. The label must include the radiopharmaceutical name or abbreviation, the type of diagnostic study or therapy procedure to be performed and the patient's name.

Statutory/Other Authority

ORS 453.635

Statutes/Other Implemented

ORS 453.605 - 453.807

History

PH 12-2018, minor correction filed 01/30/2018, effective 01/30/2018
PH 10-2011, f. 9-30-11, cert. ef. 10-1-11
PH 4-2007, f. & cert. ef. 3-1-07
PH 12-2006, f. & cert. ef. 6-16-06
HD 1-1991, f. & cert. ef. 1-8-91